By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
Rocket Lab's (RKLB) pivot to defense is promising, with significant contracts won, but execution risks, thin margins, and potential IP loss threaten its long-term success. The company's valuation is sensitive to its ability to secure follow-on wins and maintain cash runway.
Risk: Cash runway and potential IP loss
Opportunity: Successful HASTE demos accelerating Space Force's shift to proliferated LEO missile-warning constellations
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Born as a space company, Rocket Lab (NASDAQ: RKLB) is becoming more of a defense contractor as it matures.
Rocket Lab conducted its first-ever commercial satellite launch a little over eight years ago and has been ramping up its launches of small Electron rockets for both commercial and government customers ever since. In 2025, the company set a personal best, launching 21 times. Three of those launches were Hypersonic Accelerator Suborbital Test Electron (HASTE) test flights for the U.S. military.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Expect many more such military rocket launches in the future.
In March, Rocket Lab inked its biggest launch contract ever, promising to conduct 20 HASTE launches in cooperation with defense company Kratos Defense & Security Solutions over the next four years. The Department of Defense, in turn, agreed to pay Rocket Lab $190 million for its work -- $9.5 million per launch, or roughly a 13% premium to the company's usual Electron launch cost.
Given their suborbital trajectories, the HASTE tests appeared to be designed to demonstrate Rocket Lab's ability to use its Electron rockets as hypersonic weapons for the military.
But appearances can also be deceiving.
Prior to winning the HASTE contract (also known as MACH-TB 2.0 Task Area 1), Rocket Lab's other "biggest ever" contract win was an $816 million contract to build 18 missile warning satellites for the Space Force. (And before that, it won a $515 million contract -- also for missile defense satellites.)
Apparently, the U.S. military believes Rocket Lab is getting pretty good at missile defense -- so good, in fact, that it's giving Rocket Lab yet another chance to demonstrate its proficiency. And this time, Rocket Lab won't just detect hostile missiles.
It may try to shoot them down, too.
As announced last week, the Space Force has awarded Rocket Lab $266 million to conduct at least 12, and perhaps as many as 18, suborbital rocket launches under its Rocket Systems Launch Program (RSLP). The new test launches will be conducted from a new Rocket Lab launch base in the Pacific Spaceport Complex–Alaska (PSCA) in Kodiak, Alaska, but it's not 100% clear what they are supposed to accomplish. But Sir Peter Beck, Rocket Lab's CEO, dropped a heavy hint when he observed that "cadence, iteration, and relentless execution are essential to maturing America's missile defense capabilities."
To me, this suggests that the Space Force wants Rocket Lab to develop a family of hypersonic missiles to be used for missile defense -- and probably specifically for defense against Russian and Chinese hypersonic missiles currently in development. Rocket Lab may have a new area of hypergrowth for its business, with future military orders nearly doubling.
If I'm right, Rocket Lab is now a defense contractor.
Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this.
On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are about to pop. If you’re worried you’ve already missed your chance to invest, now is the best time to buy before it’s too late. And the numbers speak for themselves:
Right now, we’re issuing “Double Down” alerts for three incredible companies, available when you join Stock Advisor, and there may not be another chance like this anytime soon.
**Stock Advisor returns as of August 2, 2026. *
Rich Smith has positions in Rocket Lab. The Motley Fool has positions in and recommends Kratos Defense & Security Solutions and Rocket Lab. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"Defense contracts are now the primary growth engine for Rocket Lab, likely driving the majority of incremental revenue by 2028."
The $266M RSLP award plus the $190M Kratos HASTE deal signals Rocket Lab (RKLB) is successfully pivoting from small-sat launcher to multi-domain defense contractor. Combined with the existing $816M and $515M missile-warning satellite contracts, defense now looks set to eclipse launch revenue within 2-3 years. At 11.2x 2026E sales the stock is not cheap, but 40%+ CAGR in DoD bookings and vertical integration on Electron-derived hypersonics could justify re-rating toward 15-18x if test cadence hits 10+ launches/year.
The article glosses over that these are still mostly suborbital test contracts with low single-digit margins, not firm production orders for operational hypersonic weapons; RKLB's core Electron launch business remains unprofitable and faces intensifying competition from SpaceX and Firefly, so any delay in hypersonic maturation could leave the company burning cash for years.
"Rocket Lab is successfully transitioning from a niche launch provider to a critical defense contractor, which provides a more stable, long-term revenue floor for its high-growth valuation."
Rocket Lab (RKLB) is undergoing a structural pivot from a launch provider to a vertically integrated defense prime. While the $266 million RSLP contract is significant, the real value lies in the company's transition from providing launch services to developing proprietary spacecraft and hypersonic test vehicles. By securing large-scale government contracts for both satellite manufacturing and suborbital testing, RKLB is de-risking its revenue stream, moving away from the volatility of commercial satellite launches. However, investors must note that defense margins are often thinner than commercial launch margins, and the company remains cash-flow negative, making its valuation highly sensitive to the execution of these multi-year government programs.
The pivot to defense may actually constrain RKLB's growth by tethering it to slow-moving government procurement cycles and intense regulatory oversight, potentially eroding the agility that made its Electron rocket successful.
"RKLB has won real defense contracts, but they remain test-phase programs with no production commitment, and the article overstates the revenue impact by treating option value as certainty."
The article conflates three separate contract wins into a narrative of explosive defense growth, but the math doesn't support hypergrowth claims. RKLB has won ~$1.27B in cumulative contracts (HASTE, RSLP, missile warning satellites) over multiple years—real money, but spread thin. The $266M RSLP deal is 12-18 launches at ~$15-22M each, barely above the $9.5M HASTE rate. More concerning: these are *test* programs, not production orders. The article assumes RSLP validates a 'family of hypersonic missiles,' but the Space Force hasn't committed to production scale or timeline. RKLB's core Electron business (21 launches in 2025) generates maybe $200M annual revenue; defense contracts are accretive but not transformative at current volumes. The stock trades on optionality, not demonstrated demand.
If these test programs prove successful and the DoD moves to production orders (which historically follow successful DARPA/Space Force demos), RKLB could see 3-5x revenue uplift within 3-5 years—making today's valuation a bargain. The article may be understating the strategic importance of hypersonic missile defense to U.S. military posture.
"Most of the $266 million is for testing and development, not a guaranteed, durable revenue stream; real upside requires follow-on production awards and lifecycle work."
Rocket Lab is leveraging defense work, but the $266 million for 12–18 HASTE tests appears modest relative to potential revenue and backlog. The tests are largely R&D/qualification, not guaranteed long-term production or margin expansion, and funding depends on continued defense priorities and favorable contract awards. Alaska Kodiak logistics, export controls, and competition from larger primes add risk to sustaining any growth beyond the initial program. The article’s upbeat framing may gloss over timing risk and the uncertain path from test launches to sustained, profitable production. Overall, the news is supportive but not a slam-dunk catalyst without follow-on wins.
But if HASTE delivers proven hypersonic capability and unlocks guaranteed follow-on production, Rocket Lab could convert this into a meaningful, multi-year revenue stream that justifies higher valuations.
"RSLP success likely cross-pollinates with existing $816M+ satellite contracts faster than test-to-production timelines suggest."
Claude's math on the $266M RSLP spread across 12-18 launches is accurate but misses that these contracts often include non-recurring engineering and vehicle production revenue, not just per-launch fees. Nobody has flagged the second-order risk: successful HASTE demos could accelerate Space Force's shift to proliferated LEO missile-warning constellations where RKLB already holds prime positions, creating a self-reinforcing revenue flywheel.
"Rocket Lab's defense pivot risks commoditization, where the DoD forces them to license IP to larger, more politically entrenched prime contractors."
Grok, your 'flywheel' theory ignores the prohibitive cost of scaling. Claude is right about the thin margins, but the real danger is the 'prime' trap. By pivoting to defense, RKLB risks becoming a glorified subcontractor for Lockheed or Northrop, who have the political lobbying power to eventually cannibalize RKLB’s IP. We are ignoring the 'make vs. buy' risk: once these hypersonic test vehicles are proven, the DoD will likely force RKLB to license the tech to larger, cheaper manufacturers.
"RKLB's bottleneck is liquidity, not leverage—the DoD won't steal IP from a company that runs out of cash before proving the concept."
Gemini's 'prime trap' concern is real, but the licensing risk assumes RKLB remains a junior partner. Grok's flywheel logic actually cuts the other way: if RKLB controls the Electron-derived hypersonic platform *and* holds prime contracts on satellite constellations, the IP becomes harder to strip. The real vulnerability is cash runway—not IP theft. If RKLB burns $50-100M annually on R&D while waiting for production orders, equity dilution could erase shareholder value before any flywheel ignites.
"Runway risk is the decisive factor: without near-term production wins, the defense pivot may erode equity value even if HASTE and RSLP prove technically successful."
The key missing variable is runway. Even if HASTE converges toward production, RKLB faces multi-year ramp costs and potential dilution before DoD orders materialize. A 50-100M annual R&D burn could erode equity value faster than a hypothetical 3-5x revenue uplift, making current multiples look optimistic absent clear near-term production wins. This also increases sensitivity to DoD budget noise and export controls, a risk that could magnify negative equity outcomes if procurement slows.
Rocket Lab's (RKLB) pivot to defense is promising, with significant contracts won, but execution risks, thin margins, and potential IP loss threaten its long-term success. The company's valuation is sensitive to its ability to secure follow-on wins and maintain cash runway.
Successful HASTE demos accelerating Space Force's shift to proliferated LEO missile-warning constellations
Cash runway and potential IP loss